Biotech - Spark Newswire

1 minute read

‘Johnson & Johnson Phase 3 A DUE Data Show Investigational Single Tablet Combination Therapy Of Macitentan And Tadalafil Significantly Improves Pulmonary Hemodynamics Versus Monotherapy In Patients With Pulmonary Arterial Hypertension’

By Happy Mohamed

Today, 2:59 AM

https://johnsonandjohnson.gcs-web.com/static-files/3137d414-8b4a-432d-bee1-16af33aa8233

JNJ

1 minute read

Clene’s Lead Amyotrophic Lateral Sclerosis Shows Improved Function, Slowed Disease Progression

By Vandana Singh

Today, 2:59 AM

Clene Inc (NASDAQ:CLNN) announced new results showing preserved ALS patient functional score (ALSFRS-R) and delayed time to clinical worsening from the…

CLNN

1 minute read

Investors Cheer Armata Pharma’s Encouraging Data From Lung Infection Candidate

By Vandana Singh

Today, 2:59 AM

Armata Pharmaceuticals Inc (NASDAQ:ARMP) announced positive topline results from the completed Phase 1b/2a SWARM-P.a. trial evaluating AP-PA02 for chronic pulmonary Pseudomonas aeruginosa infections in…

ARMP

1 minute read

BioCardia Outlines Detailed Cell Therapy Data From Heart Failure Study

By Vandana Singh

Today, 2:59 AM

BioCardia Inc (NASDAQ:BCDA) presented detailed echocardiography data from the roll-in cohort of the Phase 3 CardiAMP Cell Therapy Heart Failure Trial.…

BCDA

2 minute read

BridgeBio’s Dwarfism Candidate Shows Favorable Height Increase, Safety Profile

By Vandana Singh

Today, 2:59 AM

BridgeBio Pharma Inc (NASDAQ: BBIO) announced results from PROPEL2 Phase 2 trial of infigratinib in children with achondroplasia, a genetic condition affecting a protein in the body called the fibroblast growth factor receptor.

BBIO

1 minute read

Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer’s Treatment

By Vandana Singh

Today, 2:59 AM

The FDA has accepted Eisai Co Ltd (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) supplemental Biologics License Application (sBLA) for Leqembi (lecanemab-irmb) 100 mg/mL injection,…

BIIB

4 minute read

New Study Evaluates The Use Of Masimo PVi As An Indicator Of Fluid Responsiveness To Guide Goal-Directed Fluid Therapy In Adult Neurosurgical Patients

By Happy Mohamed

Today, 2:59 AM

Researchers Found That Noninvasive, Continuous PVi Was Equally Effective in Guiding Fluid Management As Stroke Volume Variation (SVV), an Invasive Method Requiring an Arterial Line Masimo (NASDAQ:MASI) today

MASI

1 minute read

Why Unicycive Therapeutics Stock Is Exploding Higher Monday

By Adam Eckert

Today, 2:59 AM

Unicycive Therapeutics Inc (NASDAQ: UNCY) shares are exploding higher Monday after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb, a phosphate binder that potently controls phosphate with just

UNCY

1 minute read

Ra Medical’s Electrophysiology Division Announces First Use Of Catheter Precision’s LockeT Was Successfully Used In Series Of Patients

By Happy Mohamed

Today, 2:59 AM

Catheter Precision's LockeT Successfully Used in Series of Patients FORT MILL, SC / ACCESSWIRE / March 6, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) announced today that its wholly owned subsidiary,

RMED

1 minute read

FDA
News

Cantex and Miami Cancer Institute Announce FDA Clearance for a Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain Metastases

By Benzinga Newsdesk

Today, 2:59 AM

Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions, and Baptist Health Miami Cancer

VTVT